Average Co-Inventor Count = 2.12
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. E. R. Squibb Sons, Inc. (85 from 1,624 patents)
2. Arixa Pharmaceuticals, Inc. (8 from 9 patents)
3. Pharmacia & Upjohn Company (3 from 523 patents)
4. Bristol-myers Squibb Compnay (1 from 3,684 patents)
5. Glaxo Group Limited (1 from 1,168 patents)
6. Affymax, Inc. (1 from 23 patents)
7. Skyline Antiinfectives, Inc. (1 from 1 patent)
8. Godfrey, Jollie D., Jr. (0 patent)
9. Natarajan, Sesha I. (0 patent)
10. Delaney, Norma G. (0 patent)
11. Varma, Ravi K. (0 patent)
12. Haslanger, Martin F. (0 patent)
13. Koster, William H. (0 patent)
14. Gordon, Eric M. (0 patent)
15. Dejneka, Tamara (0 patent)
100 patents:
1. 11565999 - Methods of synthesizing aztreonam derivatives
2. 11180500 - Derivatives of relebactam and uses thereof
3. 10815228 - Aztreonam derivatives and uses thereof
4. 10722521 - Beta-lactamase inhibitors and uses thereof
5. 10500211 - Beta-lactamase inhibitors and uses thereof
6. 10280161 - Aztreonam derivatives and uses thereof
7. 10093666 - Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams
8. 10085999 - Beta-lactamase inhibitors and uses thereof
9. 10047077 - Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams
10. 6562844 - Oxazolidinone combinatorial libraries, compositions and methods of preparation
11. 6531470 - Oxazolidinone combinatorial libraries, compositions and methods of preparation
12. 6368874 - Methods for hard-tagging an encoded synthetic library
13. 6239152 - Oxazolidinone combinatorial libraries, compositions and methods of preparation
14. 6087349 - Method for blocking neoplastic transformation of cells induced by ras
15. 5846839 - Methods for hard-tagging an encoded synthetic library